BE857122A - Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active - Google Patents

Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active

Info

Publication number
BE857122A
BE857122A BE179609A BE179609A BE857122A BE 857122 A BE857122 A BE 857122A BE 179609 A BE179609 A BE 179609A BE 179609 A BE179609 A BE 179609A BE 857122 A BE857122 A BE 857122A
Authority
BE
Belgium
Prior art keywords
pharmaceutical composition
active substance
controlled release
new pharmaceutical
composition allowing
Prior art date
Application number
BE179609A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE857122A publication Critical patent/BE857122A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE179609A 1976-07-27 1977-07-25 Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active BE857122A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH958876 1976-07-27

Publications (1)

Publication Number Publication Date
BE857122A true BE857122A (fr) 1978-01-25

Family

ID=4353539

Family Applications (1)

Application Number Title Priority Date Filing Date
BE179609A BE857122A (fr) 1976-07-27 1977-07-25 Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active

Country Status (27)

Country Link
JP (1) JPS5315411A (enrdf_load_html_response)
AR (1) AR216479A1 (enrdf_load_html_response)
AT (1) AT369987B (enrdf_load_html_response)
AU (1) AU515738B2 (enrdf_load_html_response)
BE (1) BE857122A (enrdf_load_html_response)
CA (1) CA1095833A (enrdf_load_html_response)
CY (1) CY1261A (enrdf_load_html_response)
DE (1) DE2732335C2 (enrdf_load_html_response)
DK (1) DK325677A (enrdf_load_html_response)
ES (1) ES461020A1 (enrdf_load_html_response)
FI (1) FI772217A7 (enrdf_load_html_response)
FR (1) FR2359607A1 (enrdf_load_html_response)
GB (1) GB1589982A (enrdf_load_html_response)
GR (1) GR65014B (enrdf_load_html_response)
HK (1) HK81884A (enrdf_load_html_response)
HU (1) HU178340B (enrdf_load_html_response)
IE (1) IE45534B1 (enrdf_load_html_response)
IL (1) IL52587A (enrdf_load_html_response)
KE (1) KE3441A (enrdf_load_html_response)
MY (1) MY8400057A (enrdf_load_html_response)
NL (1) NL176227C (enrdf_load_html_response)
NO (1) NO149874C (enrdf_load_html_response)
NZ (1) NZ184722A (enrdf_load_html_response)
PT (1) PT66850B (enrdf_load_html_response)
SE (1) SE437469B (enrdf_load_html_response)
SG (1) SG53884G (enrdf_load_html_response)
ZA (1) ZA774536B (enrdf_load_html_response)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002142A3 (en) * 1997-07-11 1999-04-15 Smithkline Beecham Plc Novel composition comprising an ssri and a beta-blocker

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS61254522A (ja) * 1985-05-02 1986-11-12 Takada Seiyaku Kk 錠剤組成物
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
GB1301849A (enrdf_load_html_response) * 1969-12-15 1973-01-04
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002142A3 (en) * 1997-07-11 1999-04-15 Smithkline Beecham Plc Novel composition comprising an ssri and a beta-blocker

Also Published As

Publication number Publication date
CA1095833A (en) 1981-02-17
NZ184722A (en) 1980-10-24
SE7708265L (sv) 1978-01-28
AU2730177A (en) 1979-02-01
NL7708162A (nl) 1978-01-31
IE45534B1 (en) 1982-09-22
NO772575L (no) 1978-01-30
JPS5726650B2 (enrdf_load_html_response) 1982-06-05
GB1589982A (en) 1981-05-20
AU515738B2 (en) 1981-04-30
DK325677A (da) 1978-01-28
HU178340B (en) 1982-04-28
IE45534L (en) 1978-01-27
HK81884A (en) 1984-11-25
DE2732335C2 (de) 1983-01-20
DE2732335A1 (de) 1978-02-02
FR2359607A1 (fr) 1978-02-24
AT369987B (de) 1983-02-25
IL52587A (en) 1980-09-16
NL176227B (nl) 1984-10-16
PT66850B (fr) 1979-03-13
NO149874C (no) 1984-07-11
ZA774536B (en) 1979-02-28
KE3441A (en) 1984-09-14
ES461020A1 (es) 1979-05-01
AR216479A1 (es) 1979-12-28
NO149874B (no) 1984-04-02
NL176227C (nl) 1985-03-18
IL52587A0 (en) 1977-10-31
ATA541377A (de) 1982-07-15
JPS5315411A (en) 1978-02-13
MY8400057A (en) 1984-12-31
SE437469B (sv) 1985-03-04
SG53884G (en) 1985-03-08
FI772217A7 (enrdf_load_html_response) 1978-01-28
CY1261A (en) 1984-11-23
FR2359607B1 (enrdf_load_html_response) 1980-02-22
GR65014B (en) 1980-06-13
PT66850A (fr) 1977-08-01
DK325877A (da) 1978-01-20

Similar Documents

Publication Publication Date Title
NO771211L (no) Fremgangsm}te ved fremstilling av nye anthelmintiske midler
BE852444A (fr) Compositions pharmaceutiques anti-inflammatoires
BE884760A (fr) Comprime secable permettant une liberation controlee et retardee de la substance active
SE7812193L (sv) Fotopolymermaterial
ZA762109B (en) Microcapsule insecticide composition
AR218559A1 (es) Dosimetro para la supervision de trabajadores
BE861788A (fr) Composition de degagement pour agent biologiquement actif
BE878306R (fr) Nouvelle forme de dosage
DK524080A (da) Farmaceutiske midler indeholdende et kortikosteroidt stof
AR220182A1 (es) Procedimiento para la elaboracion de percarbonato de sodio estabilizado
NO148596C (no) Fremgangsmaate for fremstilling av 1-hydroksylerte vitamin d forbindelser
BE857122A (fr) Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active
AR213736A1 (es) Procedimiento para la preparacion de(2-(3 o 4)-alcoxi-2-piridil-(metiltio o etil)etil)-(ciano-guanidina o alquilaminonitroetileno)
IT7928192A0 (it) Procedimento per la produzione di microcapsule.
NO770782L (no) Fremgangsm}te for fremstilling av tetrazolderivater
MX5953E (es) Procedimiento mejorado para la produccion de pildoras para la liberacion controlada de productos quimicos biologicamente activos
SE439324B (sv) Forfarande for framstellning av xyloslosning ur xylanhaltiga ramaterial
BE861368A (fr) Nouvelle composition insecticide
IT1059074B (it) Piastra forata servente per la granulazione di materie artifi ciali
FR2282262A1 (fr) Nouvelle composition pharmaceutique destinee a la lutte contre des protozoaires parasites
PT65151A (fr) Procede pour la preparation de nouvelles solutions pharmaceutiques stables
SE7500547L (sv) Anordning for astadkommande av plana och relativt varandra bestemda sagsnitt medelst en kirurgisk bensag
NO146087C (no) Fremgangsmaate for fremstilling av et sjiktmateriale som halvfabrikat
MX147640A (es) Procedimiento para la preparacion de compuestos de 4 6-5-beta-sulfatoetilsulfonil-2-amino-fenol
SE7905779L (sv) Forfarande for agglomerering av fast material

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19930731